E-LIB Suche - Ergebnisse für: Kantarjian, Hagop

1

The presence of additional cytogenetic abnormalities (ACAs)..:

Haddad, Fadi G. ; Sasaki, Koji ; Issa, Ghayas C...
American Journal of Hematology. 99 (2024) 6 - p. 1175-1176 , 2024

Link: https://doi.org/10.1002/..

2

Methodological challenges in the development of endpoints f..:

Barosi, Giovanni ; Tefferi, Ayalew ; Gangat, Naseema...
The Lancet Haematology. 11 (2024) 5 - p. e383-e389 , 2024

Link: https://doi.org/10.1016/..

3

Combination therapy with novel agents for acute myeloid leu..:

Jen, Wei‐Ying ; Kantarjian, Hagop ; Kadia, Tapan M....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

4

Using Proton Pump Inhibitors is not Associated With Adverse..:

Haddad, Fadi G. ; Nasnas, Cedric ; Sasaki, Koji...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

5

Are there new relevant therapeutic endpoints in the modern ..:

Kantarjian, Hagop ; Branford, Susan ; Breccia, Massimo...
Leukemia. 38 (2024) 5 - p. 947-950 , 2024

Link: https://doi.org/10.1038/..

6

Results of ponatinib as frontline therapy for chronic myelo..:

Haddad, Fadi G. ; Sasaki, Koji ; Nasr, Lewis...
Cancer. , 2024

Link: https://doi.org/10.1002/..

7

Outcomes and genetic dynamics of acute myeloid leukemia at ..:

Bataller, Alex ; Kantarjian, Hagop ; Bazinet, Alexandre...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

8

Dose modification dynamics of ponatinib in patients with ch..:

Jabbour, Elias ; Apperley, Jane ; Cortes, Jorge...
Leukemia. 38 (2024) 3 - p. 475-481 , 2024

Link: https://doi.org/10.1038/..

9

A phase 1/2 study of mini-hyper-CVD plus venetoclax in pati..:

Short, Nicholas J. ; Jabbour, Elias ; Jain, Nitin...
Blood Advances. 8 (2024) 4 - p. 909-915 , 2024

Link: https://doi.org/10.1182/..

10

Prospective performance of the IWG-2023 criteria and IPSS-M..:

Urrutia, Samuel ; Bose, Prithviraj ; Alvarado, Yesid...
Blood Neoplasia. 1 (2024) 2 - p. 100008 , 2024

Link: https://doi.org/10.1016/..

11

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology. 11 (2024) 4 - p. e287-e298 , 2024

Link: https://doi.org/10.1016/..

12

SOHO State of the Art Updates and Next Questions | Next Que..:

Senapati, Jayastu ; Kantarjian, Hagop ; Haddad, Fadi G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 333-339 , 2024

Link: https://doi.org/10.1016/..

13

Oral decitabine–cedazuridine versus intravenous decitabine ..:

Garcia-Manero, Guillermo ; McCloskey, James ; Griffiths, Elizabeth A...
The Lancet Haematology. 11 (2024) 1 - p. e15-e26 , 2024

Link: https://doi.org/10.1016/..

14

Outcome of Patients With Relapsed Acute Promyelocytic Leuke..:

Sasaki, Koji ; Ravandi, Farhad ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 375-381 , 2024

Link: https://doi.org/10.1016/..

15

Characteristics and outcomes of patients with relapsed Phil..:

Short, Nicholas J. ; Jabbour, Elias ; Nasr, Lewis F....
American Journal of Hematology. 99 (2024) 7 - p. 1423-1426 , 2024

Link: https://doi.org/10.1002/..